WHO ICTRP trial
Observational study on newly diagnosed type 2 Diabetes patients in India
CTRI/2020/06/026076 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/06/026076 |
|---|---|
| Public title | Observational study on newly diagnosed type 2 Diabetes patients in India |
| Scientific title | A cross-sectional (baseline) & observational real world study on newly diagnosed patients with type 2 diabetes in India - IDS |
| Primary sponsor | Eris Lifesciences Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications |
| Registration date | Jun 23, 2020 |
| Target size | 13000 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: